Literature DB >> 32595356

SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.

Cihan TaŞtan1, Bulut Yurtsever1, Gözde Sir KarakuŞ1, Derya Dİlek KanÇaĞi1, Sevda Demİr2, Selen Abanuz1, Utku Seyİs1, Mülazim Yildirim1, Recai Kuzay1, Ömer Elİbol3, Serap Arbak4, Merve AÇikel Elmas4, Selçuk BİrdoĞan5, Osman Uğur Sezerman6,7, Ayşe Sesin KocagÖz8, Koray YalÇin1,9, Ercüment Ovali1.   

Abstract

The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000 cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug, isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.
Copyright © 2020 The Author(s).

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus

Year:  2020        PMID: 32595356      PMCID: PMC7314506          DOI: 10.3906/biy-2004-113

Source DB:  PubMed          Journal:  Turk J Biol        ISSN: 1300-0152


  16 in total

1.  Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.

Authors:  Yoshikazu Honda-Okubo; Dale Barnard; Chun Hao Ong; Bi-Hung Peng; Chien-Te Kent Tseng; Nikolai Petrovsky
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 2.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

Review 4.  Origin and evolution of pathogenic coronaviruses.

Authors:  Jie Cui; Fang Li; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

6.  Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.

Authors:  D Paraskevis; E G Kostaki; G Magiorkinis; G Panayiotakopoulos; G Sourvinos; S Tsiodras
Journal:  Infect Genet Evol       Date:  2020-01-29       Impact factor: 3.342

7.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

8.  T cell responses to whole SARS coronavirus in humans.

Authors:  Chris Ka-fai Li; Hao Wu; Huiping Yan; Shiwu Ma; Lili Wang; Mingxia Zhang; Xiaoping Tang; Nigel J Temperton; Robin A Weiss; Jason M Brenchley; Daniel C Douek; Juthathip Mongkolsapaya; Bac-Hai Tran; Chen-lung Steve Lin; Gavin R Screaton; Jin-lin Hou; Andrew J McMichael; Xiao-Ning Xu
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

9.  Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Authors:  Daniel H Libraty; Kimberly M O'Neil; Lauren M Baker; Luz P Acosta; Remigio M Olveda
Journal:  Virology       Date:  2007-08-13       Impact factor: 3.616

10.  The proximal origin of SARS-CoV-2.

Authors:  Kristian G Andersen; Andrew Rambaut; W Ian Lipkin; Edward C Holmes; Robert F Garry
Journal:  Nat Med       Date:  2020-04       Impact factor: 87.241

View more
  8 in total

Review 1.  Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.

Authors:  Burak Berber; Cihan Aydin; Fatih Kocabas; Gulen Guney-Esken; Kaan Yilancioglu; Medine Karadag-Alpaslan; Mehmet Caliseki; Melek Yuce; Sevda Demir; Cihan Tastan
Journal:  Gene Ther       Date:  2020-12-14       Impact factor: 5.250

2.  Can Nutritional Supports Beneficial in Other Viral Diseases Be Favorable for COVID-19?

Authors:  Fatmanur Zehra Zelka; Rümeysa Rabia Kocatürk; Öznur Özge Özcan; Mesut Karahan
Journal:  Korean J Fam Med       Date:  2022-01-20

3.  Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients.

Authors:  Badriyah Alotaibi; Thanaa A El-Masry; Mohamed G Seadawy; Bassem E El-Harty; Asmaa Saleh; Ahmed F Gad; Mostafa F El-Hosseny; Yasmen F Mahran; Maisra M El-Bouseary
Journal:  Infect Genet Evol       Date:  2022-03-31       Impact factor: 4.393

4.  Comparison of COVID-19 laboratory diagnosis by commercial kits: Effectivity of RT-PCR to the RT-LAMP.

Authors:  Yakup Artik; Alp B Coşğun; Nevra P Cesur; Nedret Hızel; Yavuz Uyar; Haydar Sur; Alp Ayan
Journal:  J Med Virol       Date:  2022-01-21       Impact factor: 20.693

5.  SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.

Authors:  Timokratis Karamitros; Gethsimani Papadopoulou; Maria Bousali; Anastasios Mexias; Sotirios Tsiodras; Andreas Mentis
Journal:  J Clin Virol       Date:  2020-08-11       Impact factor: 3.168

6.  COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy.

Authors:  Serkan Akan; Caner Ediz; Yunus Emre Kızılkan; Adem Alcin; Hasan Huseyin Tavukcu; Omer Yilmaz
Journal:  Int J Clin Pract       Date:  2020-11-09       Impact factor: 3.149

7.  UV-C (254 nm) lethal doses for SARS-CoV-2.

Authors:  Caetano P Sabino; Fábio P Sellera; Douglas F Sales-Medina; Rafael Rahal Guaragna Machado; Edison Luiz Durigon; Lucio H Freitas-Junior; Martha S Ribeiro
Journal:  Photodiagnosis Photodyn Ther       Date:  2020-09-08       Impact factor: 3.631

8.  Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure.

Authors:  Ozden Hatirnaz Ng; Sezer Akyoney; Ilayda Sahin; Huseyin Okan Soykam; Gunseli Bayram Akcapinar; Ozkan Ozdemir; Derya Dilek Kancagi; Gozde Sir Karakus; Bulut Yurtsever; Ayse Sesin Kocagoz; Ercument Ovali; Ugur Ozbek
Journal:  PLoS One       Date:  2021-12-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.